HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Johnson & Johnson (JNJ) Stock Price, Analysis & Trade Signals

$240.87+2.54 (+1.07%)

Johnson & Johnson (JNJ) operates globally, engaging in the research, development, production, and distribution of a diverse range of healthcare products. In a pivotal strategic move in 2023, the company divested its Consumer Health division, establishing it as the independent entity Kenvue Inc. This separation was implemented to allow J&J to sharpen its focus on higher-growth, innovation-led areas. Consequently, well-known consumer brands like TYLENOL, LISTERINE, and BAND-AID are now part of Kenvue's portfolio. Johnson & Johnson's current operations are centered around two primary divisions: I…

Market Cap
$567.22B
CEO
Joaquin Duato
Employees
138,100
IPO Date
1943-01-02
Website
www.jnj.com

Tabs · Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics